The GetTested Syphilis Test provides a convenient, at-home screening for Syphilis (Treponema pallidum) by detecting specific antibodies produced by your immune system in response to the Treponema pallidum bacterium. You collect a dried blood spot (DBS) sample, which is then sent to our CLIA-certified laboratory for analysis. This advanced method detects the presence of Treponema pallidum antibodies, even offering advantages over traditional venous blood draws for certain analytes, ensuring comprehensive and accurate digital results to help you understand your health status. This is an antibody detection test, not direct pathogen detection.

Anyone sexually active, especially those with new or multiple partners, or individuals experiencing potential syphilis symptoms, should consider using the GetTested Syphilis Test. Early detection of Treponema pallidum antibodies is crucial because untreated syphilis can lead to severe health complications affecting the brain, heart, and other organs. This confidential at-home testing option allows for prompt identification and linkage to post-test care and treatment, preventing progression through different stages of syphilis and onward transmission.

Our Syphilis Test is highly accurate and reliable, processed in CLIA-certified laboratories that meet stringent federal quality standards. This ensures the precise detection of Treponema pallidum antibodies. While no test is 100% foolproof, our methodology is designed for high sensitivity and specificity across various stages of syphilis infection, providing a dependable screening tool. Our physician-reviewed results offer confidence in your health status.

The GetTested Syphilis Test detects Treponema pallidum antibodies, which can persist in the bloodstream even after successful treatment. While it confirms exposure, differentiating between a past, treated infection and a current active one often requires additional testing, such as non-treponemal tests (e.g., RPR or VDRL), which measure antibody levels that typically decrease after successful treatment. For re-testing after treatment, your healthcare provider will likely use a combination of tests to monitor treatment efficacy and assess for re-infection, leveraging your initial antibody detection results as a baseline.